Celularity racks up $250 mln

Celularity, a provider of an allogeneic placental cell platform, has raised $250 million in funding. The investors included Celgene,United Therapeutics, Sorrento Therapeutics, the Dreyfus Family Office, Section 32 and Heritage Group.

Source: Press Release